A multicenter French study using full-length 16S rDNA sequencing found that men with prostate cancer harbor a more diverse ...
Since the days of Dr. Alzheimer himself, there has been a dream that severe senility might have an explanation — and a cure.
IntroductionLast time, I summarized my experiences during the first semester of the English-taught medical degree course at ...
Researchers harnessed a pathology foundation model to read endometrial biopsy slides, predicting IVF live birth outcomes and identifying the receptive phase with AUROCs up to 0.90.
Researchers at the University of Michigan report an AI tool that can forecast where aggressive brain tumours may return, ...
However, the shift to precision oncology involves therapy based more on molecular profiles and the context of an individual ...
Basal cell carcinoma is the most common skin cancer worldwide. It rarely spreads to distant parts of the body, but it can ...
Glioblastoma is the most common aggressive type of brain cancer that grows quickly into surrounding brain tissue. Even after surgery and other treatments.
Understanding how genetic variation leads to human disease requires phenotypes that capture biology at multiple scales, from tissue morphology to an individual’s overall health.
Target identification is the process of identifying the direct molecular target – for example protein or nucleic acid – of a small molecule. In clinical pharmacology, target identification is aimed at ...
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK ...
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage, AI-driven precision oncology company, today announced that it has received regulatory and IRB approvals in Taiwan to open the next stage (Part 2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results